@article{3193129,
    title = "INTERIM ANALYSIS OF PHASE 2 RESULTS FOR CEMIPLIMAB IN PATIENTS WITH
METASTATIC BASAL CELL CARCINOMA (MBCC) WHO PROGRESSED ON OR ARE
INTOLERANT TO HEDGEHOG INHIBITORS (HHIS)",
    author = "Lewis, Karl and Peris, Ketty and Sekulic, Aleksandar and Stratigos, and Alexander and Dunn, Lara and Eroglu, Zeynep and Chang, Anne Lynn and and Migden, Michael and Li, Siyu and Mohan, Kosalai and Coates, Ebony and and Okoye, Emmanuel and Baurain, Jean-Francois and Bechter, Oliver and and Hauschild, Axel and Butler, Marcus and Hernandez-Aya, Leonel and and Licitra, Lisa and Neves, Rogerio and Ruiz, Emily and Seebach, Frank and and Weinreich, David and Yancopoulos, George and Lowy, Israel and Bowler, and Timothy and Fury, Matthew",
    journal = "Journal for ImmunoTherapy of Cancer",
    year = "2020",
    volume = "8",
    number = "3",
    pages = "A260-A261",
    publisher = "BMJ Publishing Group",
    issn = "2051-1426",
    doi = "10.1136/jitc-2020-SITC2020.0428"
}